Glycemic control and heart failure among adult patients with diabetes

Circulation

Volumn 103, Issue 22, 2001, Pages 2668-2673

  Iribarren, Carlos ^a   Karter, Andrew J ^a   Go, Alan S ^a   Ferrara, Assiamira ^a   Liu, Jennifer Y ^a   Sidney, Stephen ^a   Selby, Joseph V ^a  

^a DIVISION OF RESEARCH   (United States)

Author keywords

Diabetes mellitus; Glycemia; Heart failure; Hemoglobin

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0035810983     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.103.22.2668     Document Type: Article

References (32)

1. Standards of medical care for patients with diabetes mellitus
2. The relationship of glycemic exposure (HbA1c) to the risk of development and progression of retinopathy in the diabetes control and complications trial
3. Diabetes mellitus in Egypt: Glycaemic control and microvascular and neuropathic complications
4. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus
5. Intensive blood glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
6. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: A randomized prospective 6-year study
7. Glycemic control and the risk for coronary heart disease in patients with non-insulin-dependent diabetes mellitus: The Finnish studies
8. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study
9. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
10. Role of diabetes in congestive heart failure: The Framingham study
11. Report of the national heart, lung, and blood institute special emphasis panel on heart failure research
12. Excess maternal transmission of type 2 diabetes
13. Excess costs of medical care for patients with diabetes in a managed care population
14. Estimation of the concentration of the low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
15. Evaluation and interference study of hemoglobin A1c measured by turbidimetric inhibition immunoassay
16. The Califonia automated mortality linkage system
17. The natural history of congestive heart failure: The Framingham study
18. Regression models and life tables
19. Effects of enalapril on mortality in severe congestive heart failure: Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS)
20. Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure
21. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients
22. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: A systematic overview of data from individual patients
23. Beta-blockers: The new standard of therapy for mild heart failure
24. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): A randomised trial
25. Modification of low density lipoprotein by advanced glycation end products contributes to the dyslipidemia of diabetes and renal insufficiency
26. Hyperglycemia rapidly suppresses flow-mediated endothelium-dependent vasodilation of brachial artery
27. Epidemiology of cardio-vascular complications of diabetes
28. Insulin resistance: A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease
29. Diabetic cardiomyopathy
30. Diabetic cardiomyopathy: A unique entity or a complication of coronary artery disease?
31. Cardiac consequences of diabetes mellitus
32. How have patients reacted to the implications of the DCCT?